Skip to main content
NIH funding notice RFA-NS-24-035

Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed)

Closed on December 2, 2024.

Posted
June 25, 2024
Close date
December 2, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,113,615 in first-year total cost, median $1,056,808.

Most frequent study sections

  1. Special Emphasis Panel[ZNS1 SRB-U (08)]2

Most frequent institutions

  1. J. DAVID GLADSTONE INSTITUTES1
  2. SCINTILLON INSTITUTE FOR PHOTOBIOLOGY1
Competing awards under RFA-NS-24-035 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Studying NeuroHIV and addictive substances in a human microglia-neuron chimera mouse model1R61DA065570-01GAN, LIOTT, MELANIE MARIAJ. DAVID GLADSTONE INSTITUTES, CA$1,088,600ZNS1
2025Intersection of Neuro-Immune-Vascular Dynamics in Preclinical NeuroHIV Model1R61NS145289-01PEDERSEN, IRENE MUNKSCINTILLON INSTITUTE FOR PHOTOBIOLOGY, CA$1,025,015ZNS1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-NS-24-035: Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed) | ScienceDex | ConductScience